CAPTRUST Financial Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Buy |
15,762
+1,119
| +8% | +$13K | ﹤0.01% | 2320 |
|
|
2025
Q1 | $109K | Buy |
14,643
+1,059
| +8% | +$7.87K | ﹤0.01% | 2229 |
|
|
2024
Q4 | $81.4K | Buy |
13,584
+654
| +5% | +$3.92K | ﹤0.01% | 2216 |
|
|
2024
Q3 | $66.2K | Buy |
12,930
+1,617
| +14% | +$8.28K | ﹤0.01% | 2224 |
|
|
2024
Q2 | $41K | Buy |
11,313
+1,019
| +10% | +$3.69K | ﹤0.01% | 2159 |
|
|
2024
Q1 | $33K | Sell |
10,294
-1,700
| -14% | -$5.46K | ﹤0.01% | 2101 |
|
|
2023
Q4 | $58.8K | Buy |
11,994
+539
| +5% | +$2.64K | ﹤0.01% | 2575 |
|
|
2023
Q3 | $62.4K | Sell |
11,455
-740
| -6% | -$4.03K | ﹤0.01% | 2466 |
|
|
2023
Q2 | $81.8K | Buy |
12,195
+69
| +0.6% | +$463 | ﹤0.01% | 2399 |
|
|
2023
Q1 | $107K | Buy |
+12,126
| New | +$107K | ﹤0.01% | 2151 |
|
|
2022
Q4 | – | Sell |
-12,317
| Closed | -$88K | – | 2055 |
|
|
2022
Q3 | $88K | Buy |
12,317
+11,162
| +966% | +$79.7K | ﹤0.01% | 1948 |
|
|
2022
Q2 | $9K | Sell |
1,155
-373
| -24% | -$2.91K | ﹤0.01% | 3782 |
|
|
2022
Q1 | $21K | Buy |
1,528
+758
| +98% | +$10.4K | ﹤0.01% | 3343 |
|
|
2021
Q4 | $22K | Buy |
770
+180
| +31% | +$5.14K | ﹤0.01% | 3219 |
|
|
2021
Q3 | $20K | Hold |
590
| – | – | ﹤0.01% | 3158 |
|
|
2021
Q2 | $24K | Sell |
590
-870
| -60% | -$35.4K | ﹤0.01% | 2975 |
|
|
2021
Q1 | $59K | Buy |
1,460
+270
| +23% | +$10.9K | ﹤0.01% | 2320 |
|
|
2020
Q4 | $70K | Sell |
1,190
-6
| -0.5% | -$353 | ﹤0.01% | 1679 |
|
|
2020
Q3 | $59K | Buy |
+1,196
| New | +$59K | ﹤0.01% | 1572 |
|